News & Analysis as of

Domain Names Clinical Trials

Sterne, Kessler, Goldstein & Fox P.L.L.C.

MarkIt to Market® - October 2021

The October 2021 issue of Sterne Kessler's MarkIt to Market® newsletter discusses a precedential TTAB decision regarding fraud; the DEA's proposal to increase production quotas for several schedule I controlled substances,...more

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Upping Your Branding Game, Clinically Speaking

The process of developing and bringing a drug to market is long and expensive, and from test tube to pharmacy, the competition for resources – including clinical trial participant and investor resources – is fierce. To...more

Sterne, Kessler, Goldstein & Fox P.L.L.C.

MarkIt to Market® - May 2018

The May 2018 issue of Sterne Kessler's MarkIt to Market® discusses how counterfeiting can help your brand strategy, considers the trend of "branding" clinical trials, and lists the new gTLD Sunrise Periods. ...more

Arnall Golden Gregory LLP

AGG Food & Drug Newsletter - May 2017

Arnall Golden Gregory LLP's Food and Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community, including regular updates on legislative initiatives from AGG’s Washington, DC...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide